Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kefir is a fermented milk drink produced by the action of kefir grains, which consist of a symbiotic culture of lactic acid bacteria and yeasts. It is a probiotic-rich food used in clinical settings to modulate the gastrointestinal microbiota. In the context of clinical research, kefir is being evaluated for its potential to prevent antibiotic-associated diarrhea (AAD) and *Clostridium difficile* infection (CDI) in patients undergoing systemic antibiotic treatment. The therapeutic effect is attributed to the restoration of healthy gut flora, competitive exclusion of pathogenic organisms, production of antimicrobial metabolites (such as organic acids and bacteriocins), and modulation of the host immune response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kefir (St. Luke's Duluth).